Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Sep;113(1):204–208. doi: 10.1111/j.1476-5381.1994.tb16194.x

Hydrolysis of iodine labelled urodilatin and ANP by recombinant neutral endopeptidase EC. 3.4.24.11.

Z A Abassi 1, E Golomb 1, R Agbaria 1, P P Roller 1, J Tate 1, H R Keiser 1
PMCID: PMC1510039  PMID: 7812611

Abstract

1. Urodilatin is a 32 amino-acid peptide of similar sequence to atrial natriuretic peptide (ANP), with four additional amino-acids at the N-terminus. Although ANP and urodilatin bind to the same receptors with similar affinities, urodilatin is more active than ANP as a natriuretic agent. Previous studies, using neutral endopeptidase EC 3.4.24.11 (NEP) derived from crude membrane preparations, were inconclusive, but suggested that urodilatin was more resistant than ANP to degradation by this enzyme. In the present study, we compared the degradation rates of [125I]-urodilatin and [125I]-ANP by pure recombinant NEP (rNEP). 2. Incubation of radioactively labelled ANP with rNEP resulted in a much more rapid degradation of the peptide than that for labelled urodilatin. 3. Both phosphoramidon and SQ-28,603, potent inhibitors of NEP, completely protected both peptides from metabolism by rNEP. 4. The circular dichroism spectra of the two peptides indicate that they are very similar and exist largely in unordered or flexible conformations. 5. These results support the relative resistance of urodilatin to NEP, and indicate that urodilatin may be of use as a therapeutic agent, in conditions in which ANP is ineffective.

Full text

PDF
204

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abassi Z. A., Powell J. R., Golomb E., Keiser H. R. Renal and systemic effects of urodilatin in rats with high-output heart failure. Am J Physiol. 1992 Apr;262(4 Pt 2):F615–F621. doi: 10.1152/ajprenal.1992.262.4.F615. [DOI] [PubMed] [Google Scholar]
  2. Abassi Z. A., Tate J., Hunsberger S., Klein H., Trachewsky D., Keiser H. R. Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition. Am J Physiol. 1992 Nov;263(5 Pt 1):E870–E876. doi: 10.1152/ajpendo.1992.263.5.E870. [DOI] [PubMed] [Google Scholar]
  3. Abassi Z., Burnett J. C., Jr, Grushka E., Hoffman A., Haramati A., Winaver J. Atrial natriuretic peptide and renal cGMP in rats with experimental heart failure. Am J Physiol. 1991 Oct;261(4 Pt 2):R858–R864. doi: 10.1152/ajpregu.1991.261.4.R858. [DOI] [PubMed] [Google Scholar]
  4. Abassi Z., Haramati A., Hoffman A., Burnett J. C., Jr, Winaver J. Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure. Am J Physiol. 1990 Jul;259(1 Pt 2):R84–R89. doi: 10.1152/ajpregu.1990.259.1.R84. [DOI] [PubMed] [Google Scholar]
  5. Almeida F. A., Suzuki M., Scarborough R. M., Lewicki J. A., Maack T. Clearance function of type C receptors of atrial natriuretic factor in rats. Am J Physiol. 1989 Feb;256(2 Pt 2):R469–R475. doi: 10.1152/ajpregu.1989.256.2.R469. [DOI] [PubMed] [Google Scholar]
  6. Bestle M. H., Bie P. Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs. Acta Physiol Scand. 1993 Sep;149(1):77–83. doi: 10.1111/j.1748-1716.1993.tb09594.x. [DOI] [PubMed] [Google Scholar]
  7. Booth A. G., Kenny A. J. A rapid method for the preparation of microvilli from rabbit kidney. Biochem J. 1974 Sep;142(3):575–581. doi: 10.1042/bj1420575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cavero P. G., Margulies K. B., Winaver J., Seymour A. A., Delaney N. G., Burnett J. C., Jr Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. Circulation. 1990 Jul;82(1):196–201. doi: 10.1161/01.cir.82.1.196. [DOI] [PubMed] [Google Scholar]
  9. Chiu P. J., Tetzloff G., Romano M. T., Foster C. J., Sybertz E. J. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats. Am J Physiol. 1991 Jan;260(1 Pt 2):R208–R216. doi: 10.1152/ajpregu.1991.260.1.R208. [DOI] [PubMed] [Google Scholar]
  10. Cody R. J., Atlas S. A., Laragh J. H., Kubo S. H., Covit A. B., Ryman K. S., Shaknovich A., Pondolfino K., Clark M., Camargo M. J. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest. 1986 Nov;78(5):1362–1374. doi: 10.1172/JCI112723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gagelmann M., Hock D., Forssmann W. G. Urodilatin (CDD/ANP-95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (alpha-hANP/CDD-99-126). FEBS Lett. 1988 Jun 20;233(2):249–254. doi: 10.1016/0014-5793(88)80436-8. [DOI] [PubMed] [Google Scholar]
  12. Goetz K. L. Renal natriuretic peptide (urodilatin?) and atriopeptin: evolving concepts. Am J Physiol. 1991 Dec;261(6 Pt 2):F921–F932. doi: 10.1152/ajprenal.1991.261.6.F921. [DOI] [PubMed] [Google Scholar]
  13. Goetz K., Drummer C., Zhu J. L., Leadley R., Fiedler F., Gerzer R. Evidence that urodilatin, rather than ANP, regulates renal sodium excretion. J Am Soc Nephrol. 1990 Dec;1(6):867–874. doi: 10.1681/ASN.V16867. [DOI] [PubMed] [Google Scholar]
  14. Gorman C. M., Gies D., Schofield P. R., Kado-Fong H., Malfroy B. Expression of enzymatically active enkephalinase (neutral endopeptidase) in mammalian cells. J Cell Biochem. 1989 Mar;39(3):277–284. doi: 10.1002/jcb.240390307. [DOI] [PubMed] [Google Scholar]
  15. Heim J. M., Kiefersauer S., Fülle H. J., Gerzer R. Urodilatin and beta-ANF: binding properties and activation of particulate guanylate cyclase. Biochem Biophys Res Commun. 1989 Aug 30;163(1):37–41. doi: 10.1016/0006-291x(89)92095-0. [DOI] [PubMed] [Google Scholar]
  16. Hildebrandt D. A., Mizelle H. L., Brands M. W., Hall J. E. Comparison of renal actions of urodilatin and atrial natriuretic peptide. Am J Physiol. 1992 Mar;262(3 Pt 2):R395–R399. doi: 10.1152/ajpregu.1992.262.3.R395. [DOI] [PubMed] [Google Scholar]
  17. Hoffman A., Burnett J. C., Jr, Haramati A., Winaver J. Effects of atrial natriuretic factor in rats with experimental high-output heart failure. Kidney Int. 1988 Mar;33(3):656–661. doi: 10.1038/ki.1988.49. [DOI] [PubMed] [Google Scholar]
  18. Johnson A. R., Ashton J., Schulz W. W., Erdös E. G. Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis. 1985 Sep;132(3):564–568. doi: 10.1164/arrd.1985.132.3.564. [DOI] [PubMed] [Google Scholar]
  19. Kenny A. J., Bourne A., Ingram J. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem J. 1993 Apr 1;291(Pt 1):83–88. doi: 10.1042/bj2910083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kentsch M., Ludwig D., Drummer C., Gerzer R., Müller-Esch G. Haemodynamic and renal effects of urodilatin in healthy volunteers. Eur J Clin Invest. 1992 May;22(5):319–325. doi: 10.1111/j.1365-2362.1992.tb01469.x. [DOI] [PubMed] [Google Scholar]
  21. Kirk J. E., Wilkins M. R. Effect of endopeptidase-24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat. Br J Pharmacol. 1993 Sep;110(1):350–354. doi: 10.1111/j.1476-5381.1993.tb13816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Koepke J. P., Tyler L. D., Trapani A. J., Bovy P. R., Spear K. L., Olins G. M., Blaine E. H. Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats. J Pharmacol Exp Ther. 1989 Apr;249(1):172–176. [PubMed] [Google Scholar]
  23. Koike J., Nonoguchi H., Terada Y., Tomita K., Marumo F. Effect of urodilatin on cGMP accumulation in the kidney. J Am Soc Nephrol. 1993 Apr;3(10):1705–1709. doi: 10.1681/ASN.V3101705. [DOI] [PubMed] [Google Scholar]
  24. Malfroy B., Kuang W. J., Seeburg P. H., Mason A. J., Schofield P. R. Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase). FEBS Lett. 1988 Feb 29;229(1):206–210. doi: 10.1016/0014-5793(88)80828-7. [DOI] [PubMed] [Google Scholar]
  25. Northridge D. B., Jardine A. G., Alabaster C. T., Barclay P. L., Connell J. M., Dargie H. J., Dilly S. G., Findlay I. N., Lever A. F., Samuels G. M. Effects of UK 69 578: a novel atriopeptidase inhibitor. Lancet. 1989 Sep 9;2(8663):591–593. doi: 10.1016/s0140-6736(89)90714-9. [DOI] [PubMed] [Google Scholar]
  26. Olins G. M., Spear K. L., Siegel N. R., Zurcher-Neely H. A. Inactivation of atrial natriuretic factor by the renal brush border. Biochim Biophys Acta. 1987 Jul 10;901(1):97–100. doi: 10.1016/0005-2736(87)90260-4. [DOI] [PubMed] [Google Scholar]
  27. Richards A. M., Crozier I. G., Espiner E. A., Yandle T. G., Nicholls M. G. Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension. Hypertension. 1993 Aug;22(2):231–236. doi: 10.1161/01.hyp.22.2.231. [DOI] [PubMed] [Google Scholar]
  28. Riegger G. A., Elsner D., Forssmann W. G., Kromer E. P. Effects of ANP-(95-126) in dogs before and after induction of heart failure. Am J Physiol. 1990 Dec;259(6 Pt 2):H1643–H1648. doi: 10.1152/ajpheart.1990.259.6.H1643. [DOI] [PubMed] [Google Scholar]
  29. Riegger G. A., Elsner D., Kromer E. P., Daffner C., Forssmann W. G., Muders F., Pascher E. W., Kochsiek K. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects. Circulation. 1988 Feb;77(2):398–406. doi: 10.1161/01.cir.77.2.398. [DOI] [PubMed] [Google Scholar]
  30. Roques B. P., Noble F., Daugé V., Fournié-Zaluski M. C., Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev. 1993 Mar;45(1):87–146. [PubMed] [Google Scholar]
  31. Saxenhofer H., Fitzgibbon W. R., Paul R. V. Urodilatin: binding properties and stimulation of cGMP generation in rat kidney cells. Am J Physiol. 1993 Feb;264(2 Pt 2):F267–F273. doi: 10.1152/ajprenal.1993.264.2.F267. [DOI] [PubMed] [Google Scholar]
  32. Saxenhofer H., Raselli A., Weidmann P., Forssmann W. G., Bub A., Ferrari P., Shaw S. G. Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. Am J Physiol. 1990 Nov;259(5 Pt 2):F832–F838. doi: 10.1152/ajprenal.1990.259.5.F832. [DOI] [PubMed] [Google Scholar]
  33. Schulz-Knappe P., Forssmann K., Herbst F., Hock D., Pipkorn R., Forssmann W. G. Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr. 1988 Sep 1;66(17):752–759. doi: 10.1007/BF01726570. [DOI] [PubMed] [Google Scholar]
  34. Stephenson S. L., Kenny A. J. The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11. Biochem J. 1987 Apr 1;243(1):183–187. doi: 10.1042/bj2430183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ura N., Carretero O. A., Erdös E. G. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. Kidney Int. 1987 Oct;32(4):507–513. doi: 10.1038/ki.1987.239. [DOI] [PubMed] [Google Scholar]
  36. Valentin J. P., Humphreys M. H. Urodilatin: a paracrine renal natriuretic peptide. Semin Nephrol. 1993 Jan;13(1):61–70. [PubMed] [Google Scholar]
  37. Valentin J. P., Sechi L. A., Qui C., Schambelan M., Humphreys M. H. Urodilatin binds to and activates renal receptors for atrial natriuretic peptide. Hypertension. 1993 Apr;21(4):432–438. doi: 10.1161/01.hyp.21.4.432. [DOI] [PubMed] [Google Scholar]
  38. Vanneste Y., Michel A., Dimaline R., Najdovski T., Deschodt-Lanckman M. Hydrolysis of alpha-human atrial natriuretic peptide in vitro by human kidney membranes and purified endopeptidase-24.11. Evidence for a novel cleavage site. Biochem J. 1988 Sep 1;254(2):531–537. doi: 10.1042/bj2540531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Villarreal D., Freeman R. H., Johnson R. A. Renal effects of ANF (95-126), a new atrial peptide analogue, in dogs with experimental heart failure. Am J Hypertens. 1991 Jun;4(6):508–515. doi: 10.1093/ajh/4.6.508. [DOI] [PubMed] [Google Scholar]
  40. Wilkins M. R., Settle S. L., Stockmann P. T., Needleman P. Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6465–6469. doi: 10.1073/pnas.87.16.6465. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES